Clinical Trials Directory

Trials / Completed

CompletedNCT05423756

INSPIRE Trial for Skin and Soft Tissue Infections

The INSPIRE-ASP Trial (INtelligent Stewardship Prompts to Improve Real-Time Empiric Antibiotic Selection for Patients) for Skin and Soft Tissue (SST) Infections

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
118,562 (actual)
Sponsor
Harvard Pilgrim Health Care · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The INSPIRE Skin and Soft Tissue Infection trial is a cluster-randomized controlled trial of HCA Healthcare hospitals comparing routine empiric antibiotic stewardship practices with real-time, precision medicine computerized physician order entry (CPOE) smart prompts providing the probability that a non-critically ill adult admitted with skin and soft tissue infection is infected with a resistant pathogen. Note: enrolled "subjects" represent 102 individual HCA Healthcare hospitals that have been randomized into 92 clusters. Hospitals were grouped into the same randomization cluster if they shared campuses or antibiotic stewardship staff.

Conditions

Interventions

TypeNameDescription
OTHERArm 1: Routine CareRoutine Antibiotic Stewardship Arm - Continuation of antibiotic stewardship activities in accordance with national standards.
OTHERArm 2: INSPIRE Stewardship Bundle for Skin and Soft Tissue InfectionQuality improvement intervention that includes (1) computerized physician order entry (CPOE) decision support alert that provides physicians with patient-specific risk estimates for having a skin/soft tissue infection due to a multidrug-resistant organism (MDRO) and recommends standard spectrum antibiotics for low risk patients in the first 3 days of hospitalization; (2) clinician feedback reports, and (3) activities to support CPOE adoption (including education and alignment of CPOE workflows). Other antibiotic stewardship activities to continue in accordance with national standards.

Timeline

Start date
2023-01-01
Primary completion
2024-05-09
Completion
2024-05-09
First posted
2022-06-21
Last updated
2025-08-26
Results posted
2025-08-26

Locations

102 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05423756. Inclusion in this directory is not an endorsement.